Search

Author/Creator Jones, D T W

1. Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. (10th April 2018)

Authors:
Wirsching, H -G; Tabatabai, G; Roelcke, U; Hottinger, A F; Jörger, F; Schmid, A; Plasswilm, L; Schrimpf, D; Mancao, C; Capper, D; Conen, K; Hundsberger, T; Caparrotti, F; von Moos, R; Riklin, C; Felsberg, J; Roth, P; Jones, D T W; Pfister, S; Rushing, E J
Journal:
Annals of oncology
Issue:
Volume 29:Number 6(2018)
Page Start:
1423
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. OS11.5.A PATZ1 fusions define a novel molecularly distinct CNS tumor entity with a broad histological spectrum. (9th September 2021)

Authors:
Al Halabi, K T; Sievers, P; Stichel, D; Sommerkamp, A C; Sill, M; Jäger, N; Wittmann, A; Kramm, C; Snuderl, M; Pfister, S M; von Deimling, A; Sahm, F; Jones, D T W
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 2 (2021)
Page Start:
ii14
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search